Safety and Efficacy Evaluation of SMZ1 With Ranibizumab in Patients With Neovascular Age-related Macular Degeneration Without Polypoidal Choroidal Vasculopathy
Clinical trial NCT07695207 · RECRUITING
Trial details
- NCT number
- NCT07695207
- Sponsor
- SANGMYUNG innovation
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-15
- Primary completion
- 2027-12-01
- Enrollment
- 266
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.